
Company Info
Year Established2022
Contacts
Dongxing Zha, Ph.D.Co-Founder & CEO
Company Description
Ypsilon Tx develops T cell receptor mimics(TCRm) against validated tumor antigens.

Ypsilon Tx develops T cell receptor mimics(TCRm) against validated tumor antigens.